Figure 5.
Time course of inhibition of ADP–induced platelet aggregation after 5 mg, 7 mg, 10 mg, and 12 mg sibrafiban or placebo. ▪ 5 mg, ○ 7 mg, • 10 mg, □ 12 mg sibrafiban, ▵ placebo.
Time course of inhibition of ADP–induced platelet aggregation after 5 mg, 7 mg, 10 mg, and 12 mg sibrafiban or placebo. ▪ 5 mg, ○ 7 mg, • 10 mg, □ 12 mg sibrafiban, ▵ placebo.